NCT04376060

Brief Summary

The primary aim of this study is to clinically, radiographically and histologically evaluate the lateral bone augmentation of the soft porcine cortical lamina (OsteoBiol®) using equine-derived bone particles (OsteoBiol®)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 4, 2017

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2019

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 28, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 6, 2020

Completed
5 months until next milestone

Results Posted

Study results publicly available

October 12, 2020

Completed
Last Updated

October 12, 2020

Status Verified

September 1, 2020

Enrollment Period

1.8 years

First QC Date

April 28, 2020

Results QC Date

May 17, 2020

Last Update Submit

September 17, 2020

Conditions

Keywords

osteogenesisxenograftmembrane

Outcome Measures

Primary Outcomes (4)

  • Change From Baseline in Radiological Bone Width Augmentation at 0 mm

    Width difference measured at the top of the crest (0 mm) at the site of implant placement, measured in mm over superimposition of pre-operative (baseline) Cone Beam Computed Tomography and postoperative (at 6 months) Cone Beam Computed Tomography (CBCT). The value measured at 6 months minus the value measured at baseline = width difference measured at top of the crest (0 mm).

    Six months after the regeneration procedure

  • Change From Baseline in Radiological Bone Width Augmentation at 2 mm

    Width difference measured at 2 mm of the top of the crest at the site of implant placement, measured in mm over superimposition of pre-operative (baseline) Cone Beam Computed Tomography and postoperative (at 6 months) Cone Beam Computed Tomography (CBCT). The value measured at 6 months minus the value measured at baseline = width difference measured at 2 mm of the top of the crest.

    Six months after the regeneration procedure

  • Change From Baseline in Radiological Bone Width Augmentation at 4 mm

    Width difference measured at 4 mm of the top of the crest at the site of implant placement, measured in mm over superimposition of pre-operative (baseline) Cone Beam Computed Tomography and postoperative (at 6 months) Cone Beam Computed Tomography (CBCT). The value measured at 6 months minus the value measured at baseline = width difference measured at 4 mm of the top of the crest.

    Six months after the regeneration procedure

  • Change From Baseline in Radiological Bone Width Augmentation at 6 mm

    Width difference measured at 6 mm of the top of the crest at the site of implant placement, measured in mm over superimposition of pre-operative (baseline) Cone Beam Computed Tomography and postoperative (at 6 months) Cone Beam Computed Tomography (CBCT). The value measured at 6 months minus the value measured at baseline = width difference measured at 6 mm of the top of the crest.

    Six months after the regeneration procedure

Secondary Outcomes (7)

  • Number of Implants Placed at 6 Months From the Regeneration Procedure

    Six months after the regeneration procedure

  • Change From Baseline in Radiological Bone Height Augmentation in mm Measured Buccally

    Six months after the regeneration procedure

  • Bone Percentage Superficially

    Six months after the regeneration procedure

  • Change From Baseline in Radiological Bone Height Augmentation in mm Measured Medially

    Six months after the regeneration procedure

  • Change From Baseline in Radiological Bone Height Augmentation in mm Measured Lingually

    Six months after the regeneration procedure

  • +2 more secondary outcomes

Study Arms (1)

Study population

EXPERIMENTAL

Fifteen patients (1 male, 14 females) aged between 27 and 64 years old

Device: Gen-Os®; The soft lamina (OsteoBiol®)

Interventions

The xenograft used in this study was the Gen-Os® by OsteoBiol; as described by the manufacturer, it is a carbonated nanocrystal bone mineral and collagen of natural heterologous origin, obtained by the treatment of cortical bone tissue of equine origins. Its granulometry ranges between 0.25 to 1 mm and it is described as being slightly radiopaque. The soft lamina (OsteoBiol®) used is a 35x35mm medium curved membrane of porcine origins. Its clinical indications as described by the fabricator: a co-adjuvant for the reconstruction or the partial or complete recovery of lost bone portions, fillers of non-infected, non-sclerotic and well blood bedewed bone defects.

Study population

Eligibility Criteria

Age27 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • systematically healthy
  • good oral hygiene (FMPS and FMBS \<20%).
  • having ridges with deficiencies in width (\<4 mm, Cawood and Howell class IV) which did not allow correct implant placement.

You may not qualify if:

  • pregnant and lactating women,
  • patients suffering from a systematic disease
  • patients on bisphosphonates
  • smokers (\>10 cigarettes/day)
  • patients needing vertical augmentations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sarah Khalil

Beirut, 1200, Lebanon

Location

Related Publications (3)

  • Rossi R, Rancitelli D, Poli PP, Rasia Dal Polo M, Nannmark U, Maiorana C. The use of a collagenated porcine cortical lamina in the reconstruction of alveolar ridge defects. A clinical and histological study. Minerva Stomatol. 2016 Oct;65(5):257-68.

    PMID: 27580650BACKGROUND
  • Deepika-Penmetsa SL, Thomas R, Baron TK, Shah R, Mehta DS. Cortical lamina technique: A therapeutic approach for lateral ridge augmentation using guided bone regeneration. J Clin Exp Dent. 2017 Jan 1;9(1):e21-e26. doi: 10.4317/jced.53008. eCollection 2017 Jan.

    PMID: 28149458BACKGROUND
  • Wachtel H, Fickl S, Hinze M, Bolz W, Thalmair T. The bone lamina technique: a novel approach for lateral ridge augmentation--a case series. Int J Periodontics Restorative Dent. 2013 Jul-Aug;33(4):491-7. doi: 10.11607/prd.1248.

    PMID: 23820709BACKGROUND

Limitations and Caveats

Technical problems with histomorphometric measurements: the distinction between pre-existent and newly formed bone was not possible in all the histological cuts

Results Point of Contact

Title
Dr Sarah Khalil
Organization
Saint Joseph University

Study Officials

  • Carole Chakar, PhD

    Saint-Joseph University

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Fourteen patients (1 male, 13 females) aged between 27 and 64 years old were selected from the Department of Periodontology of the Faculty of Dentistry, Saint Joseph University Beirut.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 28, 2020

First Posted

May 6, 2020

Study Start

April 4, 2017

Primary Completion

January 31, 2019

Study Completion

January 31, 2019

Last Updated

October 12, 2020

Results First Posted

October 12, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
As soon as the study is published (summer 2020)
Access Criteria
Publication in a scientific journal

Locations